Status:
COMPLETED
Does Fluoxetine Have an Effect on the CNS CRF Systems in Women Abused in Childhood?
Lead Sponsor:
Emory University
Collaborating Sponsors:
Eli Lilly and Company
Conditions:
Major Depressive Disorder
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
The primary objective of this project is to determine whether treatment with the SSRI, fluoxetine versus placebo reverses alterations in the central CRF system induced by early life stress experiences...
Detailed Description
We compare indices of central CRF activity (i.e. ACTH and cortisol response to CRF stimulation test) before and after 8 weeks of treatment with either fluoxetine or placebo between women with a histor...
Eligibility Criteria
Inclusion
- For all subjects female gender;
- For subjects assigned to the MDD groups, current DSM-IV diagnosis of MDD;
- For subjects assigned to the early-life stress group, repeated (once per month or more for at least year) sexual or physical abuse before the age of 12 years by a perpetrator at least 5 years older at the time;
- For all subjects, age of 18 to 45 years;
- Regular menstrual cycle and assessment in the early follicular phase as verified by sex steroid measures.
Exclusion
- For all subjects, gender identity disorders;
- For all subjects assigned to non-MDD groups, DSM-IV diagnosis of current MDD;
- For all subjects assigned to the group without early-life stress, major stress experiences before the age of 12 years, such as separation from parents, neglect, parental loss, accidents, severe illness or natural disaster;
- For all subjects, significant medical illness, such as gastrointestinal, neurological, endocrine, cardiovascular, pulmonary, renal, hepatic, immunological or hematological disease, organic brain disease, or cancer as determined by history, physical examination, ECG, and laboratory tests;
- Pregnancy or nursing;
- For all subjects, past or current presence of psychotic symptoms or bipolar disorder;
- For all subjects, current presence of psychoactive substance abuse/dependency or eating disorders;
- For all subjects, hormonal medication;
- For all subjects, psychotropic medication in the four weeks prior to study entry;
- For all subjects, inability to provide informed consent.
Key Trial Info
Start Date :
December 1 1997
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2007
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00208897
Start Date
December 1 1997
End Date
November 1 2007
Last Update
November 11 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Psychiatry and Behavioral Sciences
Atlanta, Georgia, United States, 30322